cjc 1295 ipamorelin and testosterone CJC-1295 + cjc-1295 ipamorelin effect on testosterone

10.1016/j.ecoenv.2013.02.020 231 SchindlerD

Acknowledgements: CRAM:Research Ireland:13/RC/2073_P2,SENSOME Disclosure of interest: All authors:nothing to disclose 1 - ICH & SAH 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P740 - ESOC25-498 HEMATOMA LOCATION AND SYMPTOM ONSET TO SAMPLING ARE PREDICTORS OF GFAP RELEASE INTO PLASMA IN ACUTE INTRACEREBRAL HEMORRHAGE Sabina Zylyftari 1 , Love-Preet Kalra 1 , Sebastian Luger 1 , Stephan Barthelmes 1 , Kristaps Blums 1 , Christian Foerch 1 1 RKH Klinikum Ludwigsburg, Ludwigsburg, Germany Background and Aims: GFAP (glial fibrillary acidic protein) is a promising biomarker for distinguishing intracerebral hemorrhage (ICH) from ischemic stroke in the prehospital phase

RB: Methodology, Investigation

Results: ePWV showed superior predictive value for poor functional outcome (AUC: 0.77, 95%CI: 0.74-0.79) at 3 months post-stroke

GlutamateGlutamine Cycle and Glutaminolysis The biochemical conversion of glutamine to glutamate and vice versa is called the glutamateglutamine cycle

(4 minutes) Video 2: Overview of Lynch syndrome (7 minutes) Video 3: Tumour testing: Identifying patients likely to have Lynch syndrome (5 minutes) Video 4: Understanding genetic testing, and patient management thereafter (11 minutes) RM Partners - West London Cancer Alliance hosted by The Royal Marsden NHS Foundation Trust There is a wealth of education, training and support materials available via the RM Partners - West London Cancer Alliance website, including: What causes Lynch Syndrome